Resmed Inc
OTC:RSMDF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Resmed Inc
OTC:RSMDF
|
US |
Intrinsic Value
The intrinsic value of 
Resmed Inc (RSMDF) under the Base Case is 16.43 USD per share.
Compared with the current market price of 22.61 USD, the stock appears
Overvalued by 27% .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Resmed Does
Resmed makes devices and software for people with sleep apnea, COPD, and other breathing disorders. Its main products are CPAP and bilevel machines, masks, and other patient interface products that help people breathe more easily at home while they sleep. It also sells cloud-connected software that helps doctors, sleep clinics, and home medical equipment providers track treatment and manage patients.
- Headquarters
- United States of America US
- Employees
- 10 600
- IPO date
- Jun 1, 1995
Resmed has a narrow economic moat
Patents limit direct copying of Resmed’s breathing devices and masks, while its software makes replacing established care systems time-consuming. These protections help it retain customers, although rivals can still compete with different product designs.
Read the full moat analysis
Revenue & Expenses Breakdown
Resmed Inc
Earnings Waterfall
Resmed Inc
The intrinsic value for Resmed Inc (RSMDF) under the Base Case is 16.43 USD.
Compared with the current market price of 22.61 USD, the stock appears Overvalued by 27% .